characterization of the complementarity determining regions in immunoglobulin by the 6-mers which are most variable in the hiv-1 genome.

NLM AIDSLINE Characterization of the complementarity determining regions in immunoglobulin by the 6-mers which are most variable in the HIV-1 genome. Takiguchi K; Doi H; Fujitsu Labs. Ltd., Chiba, Japan.
December 30, 1994

Int Conf AIDS. 1994 Aug 7-12;10(2):84 (abstract no. PA0218). Unique OBJECTIVE: To estimate the characteristics of complementarity determining regions (CDRs) in immunoglobulin (Ig) gene which are essential to interact with variable epitopes of HIV-1 proteins. METHODS: Using the data base DDBJ we analyzed CDRs in human and rodent Ig genes by the purine (u)/pyrimidine (y) 6-mers [uuyuuy], which are most variable in the HIV-1 genome (Doi, H., Proc. Natl. Acad. Sci. USA, 1991, 88, 9282-9286), and their complementary 6-mers [uyyuyy]. RESULTS: TABULAR DATA, SEE ABSTRACT VOLUME. The 6-mers [uuyuuy] and/or [uyyuyy] characteristically and differently appeared between in human and rodent Ig genes or in each CDRs of H-chain and L-chain. They most frequently appeared (87.7%) in CDR3 of human H-chain, but infrequently in CDR2 of human H-chain (29.6%). In contrast, they frequently appeared in CDR2 of rodent L-chain (81.3%), and infrequently in CDR1 of rodent H-chain (30.9%). Codon frames in the 6-mers also differed between the two species. DISCUSSION AND CONCLUSIONS: The characteristics of CDRs are different between in human and in rodents Ig. The results suggest that chimeric anti-HIV antibodies having CDRs from rodents would not effectively operate or would cause any side effect in human because of idiotype network. Animal Base Sequence Epitopes/IMMUNOLOGY Genes, Immunoglobulin Genome, Viral Human HIV Antibodies/BIOSYNTHESIS/GENETICS HIV-1/GENETICS/IMMUNOLOGY Immunoglobulins, Heavy-Chain/BIOSYNTHESIS/GENETICS Immunoglobulins, Light-Chain/BIOSYNTHESIS/GENETICS Rodentia *Variation (Genetics) ABSTRACT

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Positive living Lawyer: NY man at center of HIV scare not positive Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response CountyCare Offers Historic Opportunity to Improve Care for People with HIV International AIDS Advocates Demand China Give $1 Billion to Global Fund Kingdom of Bahrain and UNAIDS commit to intensify cooperation CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 CountyCare Offers Historic Opportunity to Improve Care for People with HIV Lawyer: NY man at center of HIV scare not positive GLOBAL: HIV Outcomes Could Improve by Integrating Treatment of Comorbid Mental Illness UNITED STATES: How Sexual Stigma Is Undermining HIV Treatment on American Indian Reservations HHS Office for Civil Rights launches campaign to increase awareness of HIPAA rights among HIV-positive Black men Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog Living with HIV Global HIV/AIDS leaders meet in SF, Oakland Ugandan youth move to front line of HIV, maternal health fight OVER 7 MILLION PEOPLE NOW RECEIVING HIV TREATMENT IN AFRICA - UN REPORT
Information in this article was accurate in December 30, 1994. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.